BBARTI RESEARCH AGENDA / PROPOSED STUDY
Finance for Small Deep-Tech Ventures
Which financing structures bridge the gap between laboratory proof and investable product?
1. Research problem
Which financing structures bridge the gap between laboratory proof and investable product? The project would examine this question within capital & financial resilience, where institutional arrangements, measurable outcomes and the costs of implementation may point in different directions. It is designed as a falsifiable research programme rather than a claim that the proposed mechanism has already been demonstrated.
2. Working proposition
Milestone-based capital with non-dilutive funding may reduce financing mismatch. This is a testable proposition, not an established result. Competing explanations and contexts in which the mechanism fails should be specified before data collection begins.
3. Research theses for examination
- Mechanism: Milestone-based capital with non-dilutive funding may reduce financing mismatch.
- Boundary conditions: Assess whether the proposition remains plausible when jurisdiction, organisational maturity, resource constraints or stakeholder interests change.
- Disconfirmation: Record which observations would favour an alternative explanation or show that the proposed approach adds no meaningful value.
4. Research design and methods
Compare funding terms and development milestones across published innovation cases. The initial protocol should establish sampling criteria, the unit of analysis, definitions of variables or legal concepts, a transparent source register, and access and ethics approvals where necessary.
5. Evidence horizon and relevant developments
WIPO’s 2026 Global Innovation Index uses roughly 80 indicators across about 140 economies, emphasising frontier science, innovation clusters and the conversion of research into enterprise. Rankings do not prove causation.
UNCTAD reports that worldwide FDI rose 6% to approximately US$1.6 trillion in 2025 while gains remained geographically uneven and concentrated in selected strategic sectors. The distribution matters more than treating a global total as an all-purpose investment signal.
The cited publications provide current institutional context and candidate sources for the literature review. They do not certify the proposed hypothesis; original empirical work, careful comparison and jurisdiction-specific validation would still be required.
6. Planned work packages
- Conceptual groundwork: Define the research object, terminology, competing frameworks and decision context.
- Evidence mapping: Create an auditable inventory of relevant primary evidence, with dates, definitions, strengths and limitations.
- Evaluation: Compare funding terms and development milestones across published innovation cases; contrast results with alternative specifications, control cases or rival interpretations.
- Critical review: Report missing observations, conflicting evidence, implementation costs and circumstances that limit transferability.
- Translation into practice: Prepare the intended practical output and an independent review checklist.
7. Anticipated research product
Deep-tech financing architecture and stage-gate model. The deliverable will be evaluated against the research question and the evidence collected.
8. Limitations, ethics and scholarly integrity
At this stage no original sample, statistical test, clinical cohort or experimental result is claimed. Any future research involving human participants, proprietary data, medical outcomes or regulated activities must obtain the applicable permissions. Publicly accessible official publications are cited for context only; their findings are not represented as findings of BBARTI.
9. Selected institutional reading
- WIPO · Global Innovation Index 2026 ↗29 September 2026
- UN Trade and Development · World Investment Report 2026 ↗7 July 2026

